List of bibliographic references
Number of relevant bibliographic references: 18.
| Ident. | Authors (with country if any) | Title |
|---|
| 000602 (2018) |
Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | The Two-Faced Cytokine IL-6 in Host Defense and Diseases. |
| 000A64 (2018) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | Interleukin (IL-6) Immunotherapy. |
| 000B47 (2017) |
Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon] | The role and therapeutic targeting of IL-6 in rheumatoid arthritis. |
| 000E07 (2016) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | Immunotherapeutic implications of IL-6 blockade for cytokine storm. |
| 001340 (2014) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | IL-6 in inflammation, immunity, and disease. |
| 001466 (2014) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] | A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. |
| 001475 (2015) |
Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi Kumanogoh | Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab. |
| 001986 (2012) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Therapeutic targeting of the interleukin-6 receptor. |
| 001A17 (2012) |
Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio Tanaka | A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 001A47 (2011) |
Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Therapeutic effect of tocilizumab on two patients with polymyositis. |
| 001A61 (2011) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. |
| 001A86 (2011) |
Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio Tanaka | Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab. |
| 001B13 (2011) |
Atsushi Ogata ; Atsuyoshi Morishima ; Toru Hirano ; Yoshihiro Hishitani ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Toshio Tanaka | Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. |
| 001B14 (2010) |
Toshio Tanaka [Japon] ; Atsushi Ogata ; Masashi Narazaki | Tocilizumab for the treatment of rheumatoid arthritis. |
| 001B40 (2010) |
Yoshihito Shima [Japon] ; Yusuke Kuwahara ; Hiroyuki Murota ; Shun Kitaba ; Mari Kawai ; Toru Hirano ; Junsuke Arimitsu ; Masashi Narazaki ; Keisuke Hagihara ; Atsushi Ogata ; Ichiro Katayama ; Ichiro Kawase ; Tadamitsu Kishimoto ; Toshio Tanaka | The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. |
| 001C23 (2010) |
Toshio Tanaka ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu Kishimoto | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 001C25 (2009) |
Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu Kishimoto | Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 001C30 (2010) |
Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio Tanaka | Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Masashi Narazaki"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i \
-Sk "Masashi Narazaki" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= PubMed
|étape= Curation
|type= indexItem
|index= Author.i
|clé= Masashi Narazaki
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
